KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Shares Issued: 2012-2025

Historic Shares Issued for Arbutus Biopharma (ABUS) over the last 12 years, with Sep 2025 value amounting to $794,000.

  • Arbutus Biopharma's Shares Issued fell 50.06% to $794,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year decrease of 11.43%. This contributed to the annual value of $7.5 million for FY2024, which is 1297.57% up from last year.
  • Arbutus Biopharma's Shares Issued amounted to $794,000 in Q3 2025, which was up 75.28% from $453,000 recorded in Q2 2025.
  • Arbutus Biopharma's 5-year Shares Issued high stood at $2.7 million for Q1 2025, and its period low was -$115,000 during Q4 2021.
  • Moreover, its 3-year median value for Shares Issued was $1.1 million (2024), whereas its average is $1.2 million.
  • As far as peak fluctuations go, Arbutus Biopharma's Shares Issued plummeted by 100.57% in 2021, and later surged by 3,191.30% in 2024.
  • Over the past 5 years, Arbutus Biopharma's Shares Issued (Quarterly) stood at -$115,000 in 2021, then crashed by 91.96% to $159,000 in 2022, then skyrocketed by 79.25% to -$46,000 in 2023, then surged by 3,191.30% to $1.4 million in 2024, then plummeted by 50.06% to $794,000 in 2025.
  • Its Shares Issued was $794,000 in Q3 2025, compared to $453,000 in Q2 2025 and $2.7 million in Q1 2025.